New Targeted Molecular Therapies for Dedifferentiated Thyroid Cancer

Dedifferentiated thyroid cancer (DeTC) derived from follicular epithelium is often incurable because it does not respond to radioiodine, radiotherapy, or chemotherapy. In cases, RET/PTC rearrangements are found in 30%–40%, RAS mutations in about 10%, and BRAF mutations in around 40%–50%, with no ove...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Antonelli, Alessandro, Ferri, Clodoveo, Ferrari, Silvia Martina, Sebastiani, Marco, Colaci, Michele, Ruffilli, Ilaria, Fallahi, Poupak
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Hindawi Publishing Corporation 2010
Gaiak:
Review Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2902220/
https://ncbi.nlm.nih.gov/pubmed/20628483
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2010/921682
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak